Previous 10 | Next 10 |
The U.S. Depart of Justice has charged 60 people , including 31 physicians, with illegally prescribing and distributing opioid painkillers. The DOJ claims that the group, which includes 53 medical professionals, are tied to ~350K prescriptions and 32M pills. More news on: Endo Internation...
By mutual agreement, INSYS Therapeutics (NASDAQ: INSY ) President & CEO Saeed Motahari has resigned . CFO Andrew Long has been promoted to CEO effective immediately. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
PHOENIX, April 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that the Board of Directors has appointed Andrew G. Long as Chief Executiv...
From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det...
In testimony before a Senate Appropriations Subcommittee about the FDA's 2020 budget request, Commissioner Scott Gottlieb, M.D. emphasized the importance of a relatively paltry additional $55M to continue the agency's work combating the opioid crisis. More news on: Endo International plc...
Privately held Purdue Pharma LP has agreed to pay the state of Oklahoma $270M to settle litigation from the AG's office over its role in the opioid crisis there. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, Stocks on...
PHOENIX, March 25, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the Company will present a poster of its pharmacokinetic (PK) study of its...
INSYS Therapeutics ( INSY -11.6% ) is down on modestly higher volume. Shares have sold off more than 21% since touching $6.59 on March 4. The stock had rallied over 80% in February before correcting. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, ...
In a statement , FDA Commissioner Scott Gottlieb, M.D. says the agency has submitted its request for $6.1B in funding for fiscal 2020, an increase of $643M from this fiscal year. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla ...
Effective in June, Health Canada will institute new regulations related to the marketing of Class B opioids, a class of painkillers equal to or stronger than morphine. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, ...
News, Short Squeeze, Breakout and More Instantly...
Insys Therapeutics Inc. Company Name:
INSY Stock Symbol:
NASDAQ Market:
Insys Therapeutics Inc. Website:
GD Entertainment and Technology’s (OTC: GDET ) Anil Idnani, CEO, will discuss the company’s 2020 outlook when he is interviewed by Stock Market Podcast. He will focus on GDET’s new customizable, prepaid ‘Dream Card’ and also the marketing of its CBD produc...
GD Entertainment and Technology (OTC: GDET ) announces today (June 15, 2020) that Anil Idnani, CEO,will be interviewed by Stock Market Podcast and offer a review of the company’s marketing growth and 2020 outlook. The company is focusing on both its re-introduced customizable, ...
Reinforcing the strength of CBD sales, website 420 Intel reported that sales of CBD hit $103 million for the month of May — the state’s first $100 million-plus month — representing a 15% jump over April and a 60% YOY spike from May last year. It was the third straight mo...